complication rate for organ transplantations
Suboptimal quality of transplanted organs
NMP is optimal, but too complex and blood-based while blood is a limited resource
*Aspired intended uses after future step-wise registrations (Omnisol is not yet available)
Biliary complications rate of 0% compared to 57% using UW solution in rat SCS syngenic and allogenic liver transplantation models1
Renal function of 45 min warm ischemia-damaged SCS preserved porcine kidneys comparable to non warm-ischemia damaged HTK controls2
Improved cold storage and oxygenated organ preservation compared to HTK in a clinically relevant porcine kidney transplantation model3
1Tanaka H et al. Efficacy of the novel preservation solution Ecosol in a rat liver transplantation model. Transplant International Vol. 31 (Suppl.2), 5–15, 11
2Kalenski J et al. Improved preservation of warm ischemia-damaged porcine kidneys after cold storage in Ecosol, a novel preservation solution. Ann Transplant 2015 Apr 27;20:233-42
3Ernst LJ et al. A new organ preservation solution for cold storage and oxygenated organ preservation; First results from a clinically relevant porcine kidney transplantation model. IMIRT 2022, Poitiers, France
1Zarnitz L et al. Taurine as Antioxidant in a Novel Cell- and Oxygen Carrier-Free Perfusate for Normothermic Machine Perfusion of Porcine Kidneys. Antioxidants. 2023 Mar 21;12(3):768
2Zarnitz L et al. Improved preservation by Omnisol compared to red blood cell based perfusate for 6 hour normothermic machine perfusion of warm ischemia-damaged porcine kidneys. Transplantation 107(10S1):p 51-52, October 2023
Dr. rer. pol.
Andreas Schumacher
Chief Executive Officer
Started multiple ventures,
Ex-BCG, former Head of RWTH Entrepreneurship Center
Dr. med.
Benedict Doorschodt
Chief Technology Officer
MedTech Founder & developer of organ preservation devices for over 20y
Dr. rer. nat.
Carola Steins-Rang
Head Regulatory & Quality
Regulatory affairs and quality management in MedTech start-ups for over 10y
Univ.-Prof. Dr. med.
René Tolba
Chief Medical Officer
Department Director at the Uni Clinic Aachen & organ preservation for over 20y
Priv. Doz. Dr. rer. medic.
Christian Bleilevens
Chief Scientific Officer
Extracorporeal organ-support and biocompatibility-research for over 10y
Univ.-Prof. Dr.
Malte Brettel
Serial founder, investor & vice rector of RWTH Aachen
M.Sc.
Marius Rosenberg
Successful founder in MedTech & investor
Prof. M.D. Ph.D. FRCS
Jiri Fronek
Head of Transplant Surgery Department at IKEM, Prague
PD Dr.
Zoltan Czigany
Consultant surgeon and machine perfusion expert
University Hospital Heidelberg
We are thrilled to share an article about Vivalyx which was published in Business Insider Gruenderszene. Please find an English translation below. Please find the
An a recent article, German „Bild Zeitung“ wrote about Vivalyx as a company that „developed a liquid for the revitalization of donor organs to increase
Aachen, 15. Juni 2023. Das Aachener LifeScience-Technologie-Start-up Vivalyx arbeitet an der Zulassung einer neuartigen Flüssigkeit zur Revitalisierung von Spenderorganen. Das Ziel ist es, die Vitalität
Get in touch with us
Tel. +49 (0)221 980 923 99
contact@vivalyx.com
Vivalyx GmbH
Philipsstr. 8
52068 Aachen
© Vivalyx 2023
All rights reserved
